Anticlastogenic potential of 1α,25-dihydroxyvitamin D3 in murine lymphoma

Cancer Letters

Volumn 150, Issue 1, 2000, Pages 1-13

  Sarkar, Alok ^a   Saha, Barun Kanti ^a   Basak, Ranjan ^a   Mukhopadhyay, Indranil ^a   Karmakar, Ranajit ^a   Chatterjee, Malay ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Chromosomal aberrations; Lymphoma; Micronucleus assay; Sister chromatid exchange; Vitamin D3

Indexed keywords

CALCITRIOL; ANTIMUTAGENIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CHROMOSOME ABERRATION; CONTROLLED STUDY; GENOTOXICITY; LYMPHOMA; MALE; MICRONUCLEUS TEST; MOUSE; MURINE LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SISTER CHROMATID EXCHANGE; TREATMENT OUTCOME; ANIMAL; BLOOD; BODY WEIGHT; BONE MARROW CELL; CANCER TRANSPLANTATION; DBA MOUSE; DRUG EFFECT; ERYTHROCYTE; GENETICS; GROWTH, DEVELOPMENT AND AGING; LIVER; METABOLISM; MICRONUCLEUS; ORGAN SIZE; PATHOLOGY;

ANIMALS; ANTIMUTAGENIC AGENTS; BODY WEIGHT; BONE MARROW CELLS; CALCITRIOL; CHROMOSOME ABERRATIONS; ERYTHROCYTES; LIVER; LYMPHOMA; MALE; MICE; MICE, INBRED DBA; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; NEOPLASM TRANSPLANTATION; ORGAN SIZE; SISTER CHROMATID EXCHANGE;

EID: 0033625006     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00327-4     Document Type: Article

References (52)

1. DeLuca H.F., Schnoes H.K. Vitamin D: Recent advances. Annu. Rev. Biochem. 52:1983;411-439.
2. Holick M.F., Schnoes H.K., DeLuca H.F., Suda T., Cousins R.J. Isolation and identification of 1,25-dihydroxyrcholecalciterol. A metabolite of Vitamin D active in intestine. Biochemistry. 10:1971;2799-2804.
3. Garland C.F., Garland F.C. Do sunlight and Vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 9:1980;227-231.
4. Hassan H.T., Eliopoulos A., Maurer H.R., Spandides D.A. Recombinant human GM-CSF enhances the anti-proliterative activity of Vitamin-D in MCF-7 human breast cancer clonogenic cells. Eur. J. Cancer 28A. 1992;1588-1589.
5. 3 in experimental hepatocarcinogenesis: specific role in synthesis of Glutathione S transferase. Neri R. Proc. XVI Int. Cancer Congress. 1994;3107-3111.
6. Studzinski G.P., Maclane J.A., Uskokovic M.R. Signal pathways for vitamin D-induced differentiation, implications for therapy of proliferative and neoplastic diseases. Crit. Rev. Eukaryot. Gene Expr. 4:1993;229-254.
7. Bouillon R., Okamura W.H., Norman A.W. Structure-function relationships in the vitamin D endocrine system. Endocr. Res. 16:1995;200-257.
8. Studzinski G.P., Moore D.C. Vitamin D and retardation of cancer progression. Watson R.R., Mufti S.I. Nutrition and Cancer Prevention. 1996;257-282 CRC Press, Boca Raton, FL.
9. Studzinski G.P., Moore D.C. Sunlight - Can it prevent, as well as cause cancer? Cancer Res. 55:1995;4011-4022.
10. Anzano M.A., Smith J.M., Uskokovic M.R., Peer C.W., Mullen L.T., Letterio J.J., Welsh M.C., Shrader M.W., Logadon D.L. 1,25-dihydroxy-16-ene-23-yne-26,27-hexaflourocholicalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res. 54:1994;1653-1656.
11. Lucia M.S., Anzano M.A., Layter M.V., Anver M.R., Green D.M., Shrader M.W., Logsdon D.L., Brown C.C., Peer C.W. Chemopreventive activity of tamoxifen N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen promoted carcinomas of rat seminal vesicle and prostate. Cancer Res. 5:1995;5621-5627.
12. 3 inbibits phorbolester-dependent chemical carcinogenesis in mouse skin. Biochem. Biophys. Res. Commun. 116:1983;605-611.
13. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology. 129:1991;832-837.
14. 3 in vivo on human osteosarcoma. J. Orthopaed. Res. 11:1993;122-130.
15. 3 treated HL60 cells. Cancer Res. 57:1997;2851-2855.
16. Wang Q.M., Jones J.D., Studzinski G.P. Cyclin-dependent kinase inhibitor p27 is a mediator of the G1 S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res. 56:1996;264-267.
17. Levan A., Levan G., Mitelman F. Chromosomes and cancer. Heriditas. 86:1977;15-30.
18. Galloway S.M., Wolf S. The relation between chemically induced sister chromatid exchanges and chromatid breakage. Mutation Res. 61:1979;277-307.
19. Sarkar A., Mukherjee B., Rana M.P., Chatterjee M. Comparative patterns of hepatic drug metabolizing enzymes and their possible correlation with chromosomal aberration in transplantable murine lymphoma - a time course study. Cancer Invest. 12:1994;477-483.
20. Rana M.P., Ghosh R., Chatterjee M. Changes in tissue levels of glutathione extent of lipid peroxidation and activity of glutathione peroxidase in transplantable murine lymphoma. Oncology. 51:1995;25-29.
21. Cerutti P.A. Prooxidant stress and tumor promotion. Science. 277:1985;375-381.
22. Wiseman H. Vitamin-D is a membrane antioxidant-ability to inhibit iron-dependant lipid peroxidation in liposomes compared to cholesterol, ergosterol, tamoxifen and relevance to anticancer action. FEBS Lett. 326:1993;285-288.
23. 3 and dietary Vitamin E on peroxidation of lipids and enyzmes of the hepatic antioxidant system in Sprague-Dawley rats. Int. J. Vit. Nutr. Res. 66:1996;39-45.
24. 3 on the activity patterns of hepatic drug metabolizing enzymes in transplantable murine lymohoma. Cancer Invest. 14:1996;328-334.
25. Mallon P., Hamilton J.G., Nauss-Karol C., Karol R.L., Asheley C.J., Matsuszewski D.S., Trantnyek C.K., Bryce G.P., Miller O.N. An improved competitive protein binding assay for 1,25-dihydroxyvitamin D. Arch. Biochem. Biophys. 201:1980;277-285.
26. Sharma A.K., Sharma A. Chromosome Technique - Theory and Practice, 3rd Edition. 1980;Butterworths, London.
27. Sarkar A., Basak R., Basak J., Bishayee A., Chatterjee M. β-Carotene inhibits rat chromosomal aberrations and DNA-chain break after a single injection of diethytnitrosamine. Br. J. Cancer. 76:1997;855-862.
28. Karmakar R., Banik S., Bandyopadhyay S., Chatterjee M. Cadmium-induced alterations of hepatic lipid peroxidation, glutathione S-transferase activity and reduced glutathione level and their possible correlation with chromosomal aberration in mice: a time course study. Mutat. Res. 397:1998;183-190.
29. Allen J.W., Shuller C.F., Mendes R.W., Latt S.A. A simplified technique for in vivo analysis of sister-chromatid exchanges using 5′-bromodeoxyuridine tablets. Cytogenet. Cell Genet. 18:1977;231-237.
30. Perry P., Wolff S. Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange. Nature (Lond.). 258:1975;121-125.
31. Steele R.G., Torres J. Principles and Procedures of Statistics. 1980;McGraw-Hill, NewYork.
32. 3. Proc. Natl. Acad. Sci. USA. 84:1987;856-860.
33. Bollag W., Peck R. Cancer chemotherapy by combinations of retinoids with cytokines and vitamin D analogs: Experimental and clincal results. Annals Oncol. 5:1994;S17-S22.
34. Chairmont A., Tessmann D., Stock A., Nicolai S., Stahl W., Sies H. Induction of gap junctional intercellular communication by vitamin D in human skin fibroblasts is dependent on the nuclear vitamin D receptor. Carcinogenesis. 17:1997;1389-1391.
35. Gilbert F. Chromosomes, genes and cancer: a classification of chromosome abnormalities in cancer. J. Natl. Cancer Inst. 71:1983;1107-1114.
36. Demopoulos H.D., Pietronigro D., Seligman M., Flamn E. The possible role of free radical reactions. J. Environ. Pathol. Toxicol. 3:1980;273-304.
37. Weitberg A.B., Weitzman S.A., Destremps M., Latt S.A., Stossel T.P. Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells. N. Engl. J. Med. 308:1983;26-29.
38. Latt S.A., Allen J., Bloom S.E., Carrano A., Falke E., Kram D., Schneider E., Schreck R., Tice R., Whitefield B., Wolff S. Sister chromatid exchanges: a report of the gene-toxicology programme. Mutat. Res. 87:1981;17-62.
39. Lambert B., Lindblad A., Holmberg L., Francesconi D. Sister Chromatid Exchange. 1982;149-182 Wiley, New York.
40. Mavournin K.H., Blakey D.H., Cimino M.C., Salamone M.F., Heedle J.A. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the US Environmental Protection Agency genetox program. Mutat. Res. 239:1990;29-80.
41. Das R.K., Kar R.N. Genotoxic effects of three benzodiazepine tranquilizers in mouse bone marrow as revealed by the micronucleus test. Caryology. 39:1986;193-198.
42. Carrano A.V., Thompson L.H., Lindl P.A., Minkler J.L. Sister chromatid exchange as an indicator of mutagenesis. Nature (Lond.). 271:1978;551-553.
43. Nishi Y., Hasegawa M.M., Taketomi M., Okhawa Y., Ini N. Comparison of 6-thiognanine-resistant mutation and sister chromatid exchanges in Chinese Hamster V79 cells with forty chemical and physical agents. Cancer Res. 44:1984;3270-3279.
44. Weitberg A.B., Weitzman S.A., Clark F.P., Stossel T.P. Effects of anti-oxidants on oxidant induced sister chromatid exchange. J. Clin. Invest. 75:1985;1835-1841.
45. Sasaki M.S. Sister chromatid exchange as possible manifestation of different DNA repair processess. Nature. 269:1977;623-625.
46. Wolff S. Hanawalt P.C., Friedberg E.C., Fox C.F. DNA Repair Mechanisms, ICN-UCLA Symposia 74 on molecular and cellular biology. Vol. 9:1978;751-760 Academic Press, New York.
47. Nowell P.C. The clonal adaptation of tumor cell proliferations. Science. 194:1976;23-28.
48. Land H., Parada L.F., Weinberg R.A. Cellular oncogenes and multistep carcinogenesis. Science. 222:1983;771-778.
49. Dewey W.C., Furman S.C., Miller H.H. Comparison of lethality and chromosomal damage induced by X-ray in synchronized Chinese Hamster cells in vitro. Radiation Res. 43:1970;561-581.
50. Fridberg E.C., Ehlmann U.K., Williams J.I. Human diseases associated with defective DNA repair. Adv. Radiat. Biol. 8:1979;85-174.
51. Kihlman B.A., Hansson K., Andersson H.C. The effects of post-treatments with caffeine during S- and G2-phases on the frequencies of chromosomal aberrations induced by thiotepa in root tips of Vicia fava. Environ. Exp. Bot. 20:1982;3043-3053.
52. 3 receptors: gene regulation and genetic circuitry, FASEB J. 2:1988;3043-3053.